ES8705229A1 - Procedimiento para la obtencion de una preparacion para aumentar la adhesion de bacterias al estomago e intestinos de seres humanos y animales - Google Patents

Procedimiento para la obtencion de una preparacion para aumentar la adhesion de bacterias al estomago e intestinos de seres humanos y animales

Info

Publication number
ES8705229A1
ES8705229A1 ES557029A ES557029A ES8705229A1 ES 8705229 A1 ES8705229 A1 ES 8705229A1 ES 557029 A ES557029 A ES 557029A ES 557029 A ES557029 A ES 557029A ES 8705229 A1 ES8705229 A1 ES 8705229A1
Authority
ES
Spain
Prior art keywords
microflora
preparations containing
adhesive effect
increased adhesive
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557029A
Other languages
English (en)
Other versions
ES557029A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemical Dynamics Sweden AB
Original Assignee
Chemical Dynamics Sweden AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemical Dynamics Sweden AB filed Critical Chemical Dynamics Sweden AB
Publication of ES557029A0 publication Critical patent/ES557029A0/es
Publication of ES8705229A1 publication Critical patent/ES8705229A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)

Abstract

METODO DE OBTENER UNA PREPARACION PARA AUMENTAR LA ADHESION AL ESTOMAGO E INTESTINOS. CONSISTE EN PRODUCIR UNA PROTEINA PROMOTORA DE ADHESION IN VIVO O UN VITRO A PARTIR DE UN CULTIVO DE BACTERIAS NO PATOGENAS. EL CULTIVO SE REALIZA EN UN CALDO QUE CONTIENE SUCROSA, FRUCTOSA Y/O GLUCOSA DE CONCENTRACION INCREMENTADA O EN UN MEDIO ACIDO CASAMINO DE CONCENTRACION INCREMENTADA. LAS BACTERIAS NO PATOGENAS SON LOS LACTOBACILOS ACIDOPHOILOS Y L BULEARICOS. SE EMPLEAN EN ANIMALES DOMESTICOS COMO CERDOS, TERNERAS, POLLOS Y OTROS.
ES557029A 1984-11-08 1986-07-16 Procedimiento para la obtencion de una preparacion para aumentar la adhesion de bacterias al estomago e intestinos de seres humanos y animales Expired ES8705229A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8405587A SE463598B (sv) 1984-11-08 1984-11-08 Preparat, avsett att oeka vidhaeftningen av bakterier till mag-tarmkanalen hos maenniskor och djur, samt ett framstaellningsfoerfarande foer detta

Publications (2)

Publication Number Publication Date
ES557029A0 ES557029A0 (es) 1987-05-16
ES8705229A1 true ES8705229A1 (es) 1987-05-16

Family

ID=20357659

Family Applications (2)

Application Number Title Priority Date Filing Date
ES549313A Expired ES8700938A1 (es) 1984-11-08 1985-11-08 Procedimiento para aumentar la adherencia de las bacterias en el estomago e intestinos de seres humanos y animales
ES557029A Expired ES8705229A1 (es) 1984-11-08 1986-07-16 Procedimiento para la obtencion de una preparacion para aumentar la adhesion de bacterias al estomago e intestinos de seres humanos y animales

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES549313A Expired ES8700938A1 (es) 1984-11-08 1985-11-08 Procedimiento para aumentar la adherencia de las bacterias en el estomago e intestinos de seres humanos y animales

Country Status (11)

Country Link
US (1) US4767623A (es)
EP (1) EP0201579B1 (es)
JP (1) JPH0720876B2 (es)
AT (1) ATE81290T1 (es)
CA (1) CA1266234A (es)
DE (1) DE3586744T2 (es)
DK (1) DK172252B1 (es)
ES (2) ES8700938A1 (es)
FI (1) FI85810C (es)
SE (1) SE463598B (es)
WO (1) WO1986002837A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
SE8900546D0 (sv) * 1989-02-17 1989-02-17 Bioinvent Int Ab Medel foer inhibering av patogeners adhesion tillvaext och /eller oeverlevnad
IL101410A0 (en) * 1992-03-29 1992-11-15 Era Masis Ltd Formulation for the treatment of cancer
AUPM823094A0 (en) * 1994-09-16 1994-10-13 Goodman Fielder Limited Probiotic compositions
JP3819441B2 (ja) * 1997-01-09 2006-09-06 森永乳業株式会社 ラクトフェリン錠剤
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
EP1082964A1 (en) * 1998-06-05 2001-03-14 Wakamoto Pharmaceutical Co., Ltd. Lactic acid bacterium-containing compositions, drugs and foods
AU768867B2 (en) * 1998-11-26 2004-01-08 Meito Sangyo Kabushiki Kaisha Bacteriostatic compositions for salmonellae
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
CN102212543A (zh) * 2005-04-15 2011-10-12 北卡罗来纳州大学 调节细菌的粘附和应激耐受力的方法和组合物
AR052472A1 (es) * 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
CA2607949C (en) * 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL294835A (es) * 1962-07-19 1900-01-01
SE371209B (es) * 1969-10-13 1974-11-11 Cernelle Ab
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
DE2738652C3 (de) * 1977-08-26 1981-02-19 Seiken Kai Foundation Juridical Person, Tondabayashi, Osaka (Japan) Lactobacillus-Präparat und seine Verwendung bei der Bekämpfung bakterieller Infektionen und Entzündungen
CH637297A5 (fr) * 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
JPS5810520A (ja) * 1981-07-10 1983-01-21 Miyarisan Kk 胆石症の治療薬
JPS5911177A (ja) * 1982-07-12 1984-01-20 Seikenkai 新規乳酸桿菌
SE8206250L (sv) * 1982-11-03 1984-05-04 Chemical Dynamics Sweden Ab Reglering av tarmmikroflora

Also Published As

Publication number Publication date
EP0201579B1 (en) 1992-10-07
SE463598B (sv) 1990-12-17
AU589384B2 (en) 1989-10-12
ES8700938A1 (es) 1986-11-16
DK172252B1 (da) 1998-02-09
WO1986002837A1 (en) 1986-05-22
CA1266234A (en) 1990-02-27
EP0201579A1 (en) 1986-11-20
AU5097285A (en) 1986-06-03
FI862863A (fi) 1986-07-07
SE8405587L (sv) 1986-05-09
US4767623A (en) 1988-08-30
JPH0720876B2 (ja) 1995-03-08
DE3586744T2 (de) 1993-04-01
DE3586744D1 (de) 1992-11-12
JPS62500722A (ja) 1987-03-26
FI85810B (fi) 1992-02-28
ATE81290T1 (de) 1992-10-15
FI862863A0 (fi) 1986-07-07
DK325486D0 (da) 1986-07-08
ES557029A0 (es) 1987-05-16
ES549313A0 (es) 1986-11-16
DK325486A (da) 1986-07-08
SE8405587D0 (sv) 1984-11-08
FI85810C (fi) 1992-06-10

Similar Documents

Publication Publication Date Title
ES8705229A1 (es) Procedimiento para la obtencion de una preparacion para aumentar la adhesion de bacterias al estomago e intestinos de seres humanos y animales
EP0233565A3 (en) Spreads having a good microbilogical stability and a fresh dairy taste
CA1268123C (en) DIETARY PRODUCTS CONTAINING METHYLSULFONYLMETHANE AND THEIR USE
AP8700068A0 (en) Vaccine and method of preparation.
FR2581310B1 (fr) Composition therapeutique comportant de l'acide a-linolenique et un compose susceptible de favoriser le passage de l'acide au travers de la membrane cellulaire et extrait de plantes comprenant l'acide et le compose
ES2055686T3 (es) Procedimiento para preparar proteinas con factor de granulocitos-macrofagos "estimulador de colonias".
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
IT8483359A0 (it) Procedimento per ottenere lapreparazione di concentrati e nutrimenti proteici dal sangue animale.
EP0181634A3 (en) Synthetic gene for human lysozyme
DE3574109D1 (en) Vaccine against diseases due to micro-organisms such as mycoplasms, preparation thereof and membranes of micro-organisms as active principle
DE69808792D1 (de) Verwendung von flüssigem kohlenhydrat-fermentationsprodukt
EP0346909A3 (en) Fermentative procedure and additive for preserving fodder
IE851369L (en) Administration of compounds to livestock as growth¹promotants
ATE237678T1 (de) Saccharomyces-behandlung zur verringerung von campylobakter- und salmonella-populationen in geflügel
GR860329B (en) Reagent for the dosage of antibodies against bacteric toxines by hemaglutination method for preparation and application thereof
DE3867477D1 (de) Zubereitung zur verlaengerung der haltbarkeit von lebensmitteln, arzneimitteln und kosmetischen produkten.
FR2598591B1 (fr) Procede de culture des procaryoyes et eucaryotes et utilisation des cellules ainsi preparees dans les compositions cosmetiques, alimentaires et des supplements au fourrage
MY100892A (en) Veterinary preparations.
JPS6480298A (en) Production of human proapolipoprotein a-i-like protein
GB1061894A (en) Therapeutically active bacterial preparations
MY101632A (en) Veterinary preparations
BG60542B2 (en) Water soluble composition having coccidiostatic effect
RU92015204A (ru) Активатор фотосинтеза (аф) - биорегулятор роста растений
Kanemoto et al. Nitrogen fixation in Rhodospirillum rubrum: The regulation of Fe protein and its activating enzyme.
Lipner Physiological considerations of the relative specificity of dental caries in man